Cephalomannine is primarily investigated for its potential in cancer treatment due to its ability to inhibit cell division by stabilizing microtubules, similar to other taxane compounds. It has shown promise in preclinical studies for its antitumor activity, particularly in targeting various cancer cell lines. Researchers are exploring its use in combination therapies to enhance efficacy and reduce drug resistance in chemotherapy. Additionally, cephalomannine is being studied for its role in improving the delivery of anticancer drugs through advanced drug delivery systems, such as nanoparticles. Its application extends to research in understanding cellular mechanisms and developing novel therapeutic strategies for challenging cancers.